ASLAN Pharmaceuticals Stock Forecast, Price & News

ASLAN Pharmaceuticals (NASDAQ:ASLN) Frequently Asked Questions

Is ASLAN Pharmaceuticals a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ASLAN Pharmaceuticals in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ASLAN Pharmaceuticals stock.
View analyst ratings for ASLAN Pharmaceuticals or view top-rated stocks.

How has ASLAN Pharmaceuticals' stock price been impacted by COVID-19 (Coronavirus)?

ASLAN Pharmaceuticals' stock was trading at $1.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ASLN shares have decreased by 32.1% and is now trading at $1.08.
View which stocks have been most impacted by COVID-19.

Are investors shorting ASLAN Pharmaceuticals?

ASLAN Pharmaceuticals saw a decrease in short interest in December. As of December 31st, there was short interest totaling 94,400 shares, a decrease of 46.1% from the December 15th total of 175,100 shares. Based on an average daily trading volume, of 433,900 shares, the short-interest ratio is currently 0.2 days. Currently, 0.2% of the shares of the company are sold short.
View ASLAN Pharmaceuticals' Short Interest.

When is ASLAN Pharmaceuticals' next earnings date?

ASLAN Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, April 28th 2022.
View our earnings forecast for ASLAN Pharmaceuticals.

How were ASLAN Pharmaceuticals' earnings last quarter?

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) posted its quarterly earnings results on Monday, October, 25th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.01.
View ASLAN Pharmaceuticals' earnings history.

What price target have analysts set for ASLN?

3 analysts have issued 1 year target prices for ASLAN Pharmaceuticals' shares. Their forecasts range from $8.00 to $8.00. On average, they expect ASLAN Pharmaceuticals' share price to reach $8.00 in the next twelve months. This suggests a possible upside of 640.7% from the stock's current price.
View analysts' price targets for ASLAN Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are ASLAN Pharmaceuticals' key executives?

ASLAN Pharmaceuticals' management team includes the following people:

• Carl Aslan Jason Morton Firth, Chief Executive Officer & Director
• Kiran Kumar Asarpota, Chief Operating Officer & Head-Finance
• Kenneth Kobayashi, Chief Medical Officer
• Stephen Doyle, Chief Business Officer
• Ferda Cevikbas, Executive Director & Head-Translational Science

Who are some of ASLAN Pharmaceuticals' key competitors?

Some companies that are related to ASLAN Pharmaceuticals include Neoleukin Therapeutics (NLTX), Larimar Therapeutics (LRMR), Anebulo Pharmaceuticals (ANEB), Sensei Biotherapeutics (SNSE), Inozyme Pharma (INZY), Alzamend Neuro (ALZN), Sesen Bio (SESN), NextCure (NXTC), Wave Life Sciences (WVE), Sol-Gel Technologies (SLGL), BeyondSpring (BYSI), ObsEva (OBSV), Landos Biopharma (LABP), NuCana (NCNA) and Aquestive Therapeutics (AQST).
View all of ASLN's competitors.

What other stocks do shareholders of ASLAN Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ASLAN Pharmaceuticals investors own include Sorrento Therapeutics (SRNE), Arbutus Biopharma (ABUS), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), OPKO Health (OPK), Onconova Therapeutics (ONTX), Aldeyra Therapeutics (ALDX), SCYNEXIS (SCYX) and VBI Vaccines (VBIV).

When did ASLAN Pharmaceuticals IPO?

(ASLN) raised $60 million in an initial public offering on Friday, May 4th 2018. The company issued 7,500,000 shares at a price of $8.05 per share. Leerink Partners and Piper Jaffray acted as the underwriters for the IPO and BTIG, H.C. Wainwright and CLSA were co-managers.

What is ASLAN Pharmaceuticals' stock symbol?

ASLAN Pharmaceuticals trades on the NASDAQ under the ticker symbol "ASLN."

How do I buy shares of ASLAN Pharmaceuticals?

Shares of ASLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ASLAN Pharmaceuticals' stock price today?

One share of ASLN stock can currently be purchased for approximately $1.08.

How much money does ASLAN Pharmaceuticals make?

ASLAN Pharmaceuticals has a market capitalization of $41.03 million and generates $3 million in revenue each year. The company earns $-16.20 million in net income (profit) each year or ($0.48) on an earnings per share basis.

How many employees does ASLAN Pharmaceuticals have?

ASLAN Pharmaceuticals employs 2,020 workers across the globe.

What is ASLAN Pharmaceuticals' official website?

The official website for ASLAN Pharmaceuticals is www.aslanpharma.com.

Where are ASLAN Pharmaceuticals' headquarters?

ASLAN Pharmaceuticals is headquartered at 83 CLEMENCEAU AVENUE 12-03 UE SQUARE, SINGAPORE U0, 239920.

How can I contact ASLAN Pharmaceuticals?

ASLAN Pharmaceuticals' mailing address is 83 CLEMENCEAU AVENUE 12-03 UE SQUARE, SINGAPORE U0, 239920. The company can be reached via phone at (656) 222-4235, via email at [email protected], or via fax at 65-6225-2419.